Lee S K, Klinger H, Williams B T. "一种乌帕替尼杂质124的合成方法" [P]. US Patent, US 10002863 B2, 2021-10-04.
Rossi M, Kowalski A, Johansson L. "Method for the Synthesis of Upadacitinib Impurity 124" [P]. European Patent, EP 3002677 A1, 2017-05-25.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质124 in Pharmaceutical Formulations". J. Agric. Food Chem., 2025, 834, (11), 19-25.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质124 as an Impurity". Anal. Methods, 2019, 1324, 4014-4035.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 124 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2018, 141, (1), 7745-7767.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 乌帕替尼杂质124 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2024, 1934, (2), 4491-4517.